PTPRC and neoplasm: The sample was subjected to CD45+ cell depletion and the isolated tumor cells (CD45− cells) were treated with a panel of targeted drugs at varying concentrations for 72 h, followed by cell viability assessment using MTS assay to determine drug efficacy.